Scarica l'app Stockscreener
12.51
2.80%
-0.36
Dopo l'orario di chiusura:
12.49
-0.02
-0.16%
Precedente Chiudi:
$12.87
Aprire:
$12.54
Volume 24 ore:
12,271
Relative Volume:
0.41
Capitalizzazione di mercato:
$25.61M
Reddito:
-
Utile/perdita netta:
$-4.85M
Rapporto P/E:
-40.35
EPS:
-0.31
Flusso di cassa netto:
$-3.95M
1 W Prestazione:
-5.87%
1M Prestazione:
+42.00%
6M Prestazione:
-28.80%
1 anno Prestazione:
+54.25%
Intervallo 1D:
$12.43
$12.75
Intervallo di 1 settimana:
$12.25
$13.25
Portata 52W:
$6.89
$22.90
Cadrenal Therapeutics Inc Stock (CVKD) Company Profile
Nome
Cadrenal Therapeutics Inc
Settore
Industria
Telefono
904-300-0701
Indirizzo
822 A1A NORTH, PONTE VEDRA
Confronta CVKD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CVKD
Cadrenal Therapeutics Inc
|
12.51 | 25.40M | 0 | -4.85M | -3.95M | -0.31 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Cadrenal Therapeutics Inc Stock (CVKD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-12-18 | Iniziato | Noble Capital Markets | Outperform |
Cadrenal Therapeutics Inc Borsa (CVKD) Ultime notizie
How institutional ownership impacts Cadrenal Therapeutics Inc. stockJuly 2025 Retail & AI Based Buy/Sell Signal Reports - Newser
Is Cadrenal Therapeutics Inc. stock forming a cup and handlePortfolio Update Report & Stock Market Timing Techniques - khodrobank.com
What momentum shifts mean for Cadrenal Therapeutics Inc.Market Growth Review & Detailed Earnings Play Strategies - Newser
Will Cadrenal Therapeutics Inc. outperform the marketMarket Growth Summary & Daily Risk Controlled Trade Plans - Newser
Cadrenal Therapeutics Inc. recovery potential after sell off2025 Valuation Update & AI Based Buy and Sell Signals - Newser
How to build a custom watchlist for Cadrenal Therapeutics Inc.Earnings Summary Report & Stepwise Trade Signal Implementation - Newser
What high frequency data says about Cadrenal Therapeutics Inc.July 2025 Sector Moves & Real-Time Volume Surge Alerts - Newser
Should you wait for a breakout in Cadrenal Therapeutics Inc.Quarterly Performance Summary & Risk Adjusted Swing Trade Ideas - Newser
How to build a dashboard for Cadrenal Therapeutics Inc. stockJuly 2025 Review & AI Optimized Trade Strategies - Newser
Is a relief rally coming for Cadrenal Therapeutics Inc. holdersQuarterly Profit Review & Smart Allocation Stock Tips - Newser
How to track smart money flows in Cadrenal Therapeutics Inc.Gap Up & High Accuracy Investment Signals - Newser
Will Cadrenal Therapeutics Inc. benefit from macro trendsPortfolio Value Summary & Growth Oriented Trade Recommendations - Newser
How to read the order book for Cadrenal Therapeutics Inc.July 2025 Trade Ideas & Free Real-Time Market Sentiment Alerts - Newser
Can Cadrenal Therapeutics Inc. navigate macro headwindsJuly 2025 Outlook & Daily Chart Pattern Signal Reports - khodrobank.com
News impact scoring models applied to Cadrenal Therapeutics Inc.Market Volume Summary & Stepwise Entry/Exit Trade Alerts - Newser
Is a relief rally coming for FTRE holdersWeekly Stock Report & Weekly Setup with High ROI Potential - Newser
Using AI based signals to follow Cadrenal Therapeutics Inc.July 2025 PostEarnings & Precise Buy Zone Identification - Newser
Real time social sentiment graph for Churchill Downs IncorporatedJuly 2025 Setups & Entry Point Confirmation Signals - Newser
Intraday pattern recognizer results for Cadrenal Therapeutics Inc.2025 Trading Recap & Growth Oriented Trade Recommendations - Newser
Fed Meeting: Can Cadrenal Therapeutics Inc. weather a recessionJuly 2025 Short Interest & Free Risk Controlled Daily Trade Plans - khodrobank.com
Live market analysis of Cadrenal Therapeutics Inc.2025 Big Picture & Precise Entry and Exit Recommendations - Newser
What is Cadrenal Therapeutics Inc.’s valuation compared to sectorTrade Exit Summary & Long-Term Capital Growth Ideas - khodrobank.com
Market reaction to Cadrenal Therapeutics Inc.’s recent news2025 Big Picture & Safe Capital Growth Tips - Newser
What to do if you’re stuck in FirstService CorporationEarnings Overview Summary & Fast Momentum Stock Entry Tips - Newser
Identifying reversal signals in Cadrenal Therapeutics Inc.2025 Trading Volume Trends & Accurate Trade Setup Notifications - Newser
Can momentum traders help lift Cadrenal Therapeutics Inc.Weekly Trend Recap & Technical Pattern Based Signals - Newser
Published on: 2025-08-31 17:29:05 - Newser
Chartists See Breakout Potential in Cadrenal Therapeutics Inc.2025 Year in Review & Daily Profit Focused Screening - beatles.ru
Order flow analysis tools used on Cadrenal Therapeutics Inc.2025 Earnings Surprises & Entry Point Strategy Guides - Newser
Best data tools to analyze Cadrenal Therapeutics Inc. stock2025 Trading Recap & High Accuracy Trade Signal Alerts - Newser
Is Cadrenal Therapeutics Inc. stock ready for a breakoutJuly 2025 Price Swings & Reliable Breakout Stock Forecasts - Newser
Using data tools to time your Cadrenal Therapeutics Inc. exitPortfolio Return Report & Low Drawdown Trading Strategies - Newser
Is this a good reentry point in Cadrenal Therapeutics Inc.Product Launch & Fast Entry Momentum Alerts - Newser
What indicators show strength in EURKRFed Meeting & Accurate Entry/Exit Alerts - Newser
Cadrenal Therapeutics Inc Azioni (CVKD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Cadrenal Therapeutics Inc Azioni (CVKD) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Szot Matthew K | Chief Financial Officer |
Aug 28 '25 |
Sale |
14.00 |
400 |
5,600 |
31,333 |
| Pham Quang X | CEO and Chairman |
Aug 27 '25 |
Sale |
13.99 |
3,836 |
53,666 |
214,497 |
| Pham Quang X | CEO and Chairman |
Aug 28 '25 |
Sale |
13.99 |
1,193 |
16,690 |
213,304 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):